 |
The Journal of Neuroscience, September 6, 2006, 26(36):9250-9263; doi:10.1523/JNEUROSCI.1856-06.2006
Previous Article | Next Article 
Neurobiology of Disease
Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors
Jelena Mojsilovic-Petrovic,1
Goo-Bo Jeong,1,2
Amanda Crocker,1
Amrita Arneja,1
Samuel David,1
David Russell,3 and
Robert G. Kalb1
1Department of Neurology, Childrens Hospital of Philadelphia, Joseph Stokes Jr. Research Institute, Philadelphia, Pennsylvania 19104, 2Department of Anatomy, College of Medicine, Chungbuk National University, Cheong-ju 361-763, Republic of Korea, and 3Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519
Correspondence should be addressed to Robert G. Kalb, Childrens Hospital of Philadelphia/Abramson Research Center #814, 3615 Civic Center Boulevard, Philadelphia, PA 19104. Email: Kalb{at}email.chop.edu
The death of motor neurons in amyotrophic lateral sclerosis (ALS) is thought to result from the interaction of a variety of factors including excitotoxicity, accumulation of toxic proteins, and abnormal axonal transport. Previously, we found that the susceptibility of motor neurons to excitotoxic insults can be limited by inhibiting signals evoked by brain-derived neurotrophic factor (BDNF) activation of the receptor tyrosine kinase B (TrkB). Here we show that this can be achieved by direct kinase inhibition or by blockade of a transactivation pathway that uses adenosine A2a receptors and src-family kinases (SFKs). Downstream signaling cascades (such as mitogen-activated protein kinase and phosphatidylinositol-3 kinase) are inhibited by these blockers. In addition to protecting motor neurons from excitotoxic insult, these agents also prevent toxicity that follows from the expression of mutant proteins (G85R superoxide dismutase 1; G59S p150glued) that cause familial motor neuron disease. TrkB, adenosine A2a receptors, and SFKs associate into complexes in lipid raft and nonlipid raft membranes and the signaling from lipids rafts may be particularly important because their disruption by cholesterol depletion blocks the ability of BDNF to render motor neurons vulnerable to insult. The neuroprotective versatility of Trk antagonism suggests that it may have broad utility in the treatment of ALS patients.
Key words: adenosine A2a receptor; brain-derived neurotrophic factor; Trk receptor; transactivation; amyotrophic lateral sclerosis; motoneuron
Received Dec. 6, 2005;
revised Aug. 4, 2006;
accepted Aug. 4, 2006.
Correspondence should be addressed to Robert G. Kalb, Childrens Hospital of Philadelphia/Abramson Research Center #814, 3615 Civic Center Boulevard, Philadelphia, PA 19104. Email: Kalb{at}email.chop.edu
This article has been cited by other articles:

|
 |

|
 |
 
L. Zhang, J. Schessl, M. Werner, C. Bonnemann, G. Xiong, J. Mojsilovic-Petrovic, W. Zhou, A. Cohen, P. Seeburg, H. Misawa, et al.
Role of GluR1 in Activity-Dependent Motor System Development
J. Neurosci.,
October 1, 2008;
28(40):
9953 - 9968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Fernandes, A. Pinto-Duarte, J. A. Ribeiro, and A. M. Sebastiao
Postsynaptic Action of Brain-Derived Neurotrophic Factor Attenuates {alpha}7 Nicotinic Acetylcholine Receptor-Mediated Responses in Hippocampal Interneurons
J. Neurosci.,
May 21, 2008;
28(21):
5611 - 5618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Kim, X. Fan, C. Gabbi, K. Yakimchuk, P. Parini, M. Warner, and J.-A. Gustafsson
Liver X receptor {beta} (LXR{beta}): A link between {beta}-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia
PNAS,
February 12, 2008;
105(6):
2094 - 2099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wiese, S. Jablonka, B. Holtmann, N. Orel, R. Rajagopal, M. V. Chao, and M. Sendtner
Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB
PNAS,
October 23, 2007;
104(43):
17210 - 17215.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|